Davis Lab

Publications

 

  1. Cotten KL, Davis KM. Bacterial heterogeneity and antibiotic persistence: bacterial mechanisms utilized in the host environment. 2023. Microbiol Mol Biol Rev, 87(4):e0017422. PMID: 37962348
     
  2. Davis KM. mSphere of Influence: If virulence is energetically costly, how can it be maintained? 2023. mSphere, 8(5):e0031223. PMID: 37676232
     
  3. DeMourdant T, Rajkovic CJ, Tracz JA, Perdomo-Pantoja A, Judy BF, Hernandez VN, Lin J, Lazzari JL, Planchard RF,Dikeman DA, Archer NK, Davis KM, Gordon O, Witham TF. A Novel Rodent Model of Chronic Spinal Implant-Associated Infection. 2023. Spine J, 23(9):1389-1399. PMID: 37247639
     
  4. *Braza RE#, *Cotten KL#, Davis KM. Protocol for detecting Yersinia pseudotuberculosis nitric oxide (NO) exposure during in vitro growth. 2022. STAR Protoc, 3(4):101760. PMID: 36219561 (# equal contribution)
     
  5. *Molom-Ochir S, Davis KM. Effects of temperature on hand sanitizer efficiency†. 2022. Journal of Emerging Investigators, 5:1-5. †manuscript completed as part of an outreach partnership with S. Molom-Ochir and Governor Thomas Johnson Middle School
     
  6. Liu B, Braza RE, Cotten KL, Davidson RK, Davis KM. NO-stressed Y. pseudotuberculosis have decreased cell division rates in the mouse spleen. 2022. Infect Immun, 90(8): e0016722. PMID: 35862700
    -submitted as bioRxiv pre-print, doi: https://doi.org/10.1101/2021.08.04.455180(link is external)
     
  7. Alvarez-Manzo HS#, Davidson RK#, Van Cauwelaert de Wyels J, Cotten KL, Nguyen BH, Xiao M, Zhu Z, Anthony J, van Opijnen T, Davis KM. Yersinia pseudotuberculosis doxycycline tolerance strategies include modulating expression of genes linked to cell permeability and tRNA modification. 2022. PLoS Pathogens, 18(5):e1010556. PMID: 35576231 (# equal contribution)
    -submitted as bioRxiv pre-print, doi:     https://doi.org/10.1101/2021.11.01.466809(link is external)
     
  8. Gordon O, Lee D, Liu B, Langevin B, Ordonez AA, Dikeman DA, Shafiq B, Thompson JM, Sponseller PD, Flavahan K, Lodge MA, Rowe SP, Dannals RF, Ruiz-Bedoya CA, Read TD, Peloquin CA, Archer NK, Miller LS, Davis KM, Gobburu JVS, Jain  SK. Dynamic PET-facilitated Modeling and High-dose Rifampin Regimens for Staphylococcus aureus Orthopedic Implant Associated Infections. 2021. Sci Transl Med, 13(622):eabl6851. doi: 10.1126/scitranslmed.abl6851. PMID: 34851697 
     
  9. Patel P, O’Hara BJ, Aunins E, Davis KM.  Modifying TIMER to generate a slow-folding DsRed derivative for optimal use in quickly-dividing bacteria. 2021. PLoS Pathog, 17(7):e1009284. PMID: 34214139 
    -submitted as bioRxiv pre-print, doi: https://doi.org/10.1101/2021.01.12.426338(link is external)
     
  10. Davidson RK, Davis KM.  Yersinia pseudotuberculosis: cultivation, storage, and methods for introducing DNA. 2020. Curr Protoc Microbiol, 59(1):e122. PMID: 33079471
     
  11. Raneses JR, Ellison AL, Liu, B, Davis KM. Subpopulations of stressed Y. pseudotuberculosis preferentially survive doxycycline treatment within host tissues. 2020. mBio, 11(4):e00901-20.PMID: 32753491
    -also submitted as bioRxiv pre-print, doi: https://doi.org/10.1101/2020.04.13.039222(link is external)
     
  12. Clark SA, Thibault D, Shull LM, Davis KM, Aunins E, van Opijnen T, Isberg RR. Topologically correct synthetic reconstruction of pathogen social behavior found during Yersinia growth in deep tissue sites. 2020. eLife, 9:e58106. PMID: 32543373 **also submitted as bioRxiv pre-print, https://doi.org/10.1101/2020.04.27.065144(link is external)
     
  13. Davis KM. For the greater (bacterial) good: heterogeneous expression of energetically costly virulence factors. Review. 2020. Infect Immun, 88(7):e00911-19. PMID: 32041785
     
  14. Davis KM, Krupp J, Clark S, Isberg RR. Iron-sulfur cluster repair contributes to Yersinia pseudotuberculosis survival within deep tissues. 2019. Infect Immun, 87(10):e00533-19. PMID: 31331956
     
  15. Davis KM, Isberg RR. One for all, but not all for one: social behavior during bacterial diseases. Review. 2019. Trends Microbiol, 27(1):64-74. PMID: 30243514
     
  16. Davis KM. All Yersinia are not created equal: phenotypic adaptation to distinct niches within mammalian tissues. Review. 2018. Front Cell Infect Microbiol, 8:261. PMID 30128305
     
  17. Davis KM, Isberg RR. Defining heterogeneity within bacterial populations via single cell approaches. Review. 2016. Bioessays, 38(8):782-90. PMID: 27273675 ncbi.nlm.nih.gov/pubmed/27273675(link is external)
     
  18. Chen Y, Lin Y, Davis KM, Wang Q, Rnjak-Kovacina J, Li C, Isberg RR, Kumamoto CA, Mecsas J, Kaplan DL. Robust bioengineered 3D functional human intestinal epithelium. 2015. Sci Rep, 5: 1370 PMID: 26374193 ncbi.nlm.nih.gov/pubmed/26374193(link is external)
     
  19. Asrat S#, Davis KM#, Isberg RR. Modulation of the host innate immune and inflammatory response by translocated bacterial proteins. Review. 2015. Cell Microbiol, 17(6): 785-95. (# equal contribution) PMID: 25850689 ncbi.nlm.nih.gov/pubmed/25850689(link is external)
     
  20. Davis KM, Mohammadi S, Isberg RR. Community behavior and spatial regulation within a bacterial microcolony in deep tissue sites serves to protect again host attack. 2015. Cell Host Microbe, 17(1): 21-31. PMID: 25500192 ncbi.nlm.nih.gov/pubmed/25500192(link is external)
     
  21. Davis KM, Isberg RR. Plague’s partners in crime. Preview. 2014. Immunity, 41(3): 347-349. PMID: 25238090 ncbi.nlm.nih.gov/pubmed/25238090(link is external)
     
  22. Davis KM, Nakamura S, Weiser JN. Nod2-sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. 2011. J Clin Invest, 121(9): 3666-3676. PMID: 21841315 ncbi.nlm.nih.gov/pubmed/21841315(link is external)
     
  23. Nakamura S, Davis KM, Weiser JN. Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. 2011. J Clin Invest, 121(9): 3657-3665. PMID: 21841308 ncbi.nlm.nih.gov/pubmed/21841308(link is external)
     
  24. Davis KM, Weiser JN. Modifications to the peptidoglycan backbone help bacteria to establish infection. Review. 2011. Infect Immun, 79(2): 562-570. PMID: 21041496 ncbi.nlm.nih.gov/pubmed/21041496(link is external)
     
  25. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. 2010. Nat Med, 16(2): 228-231. PMID: 20081863 ncbi.nlm.nih.gov/pubmed/20081863(link is external)
     
  26. Davis KM, Akinbi HT, Standish AJ, Weiser JN. Resistance to mucosal lysozyme compensates for the fitness deficit of peptidoglycan modifications by Streptococcus pneumoniae. 2008. PLoS Pathog,4(12): e1000241. PMID: 19079576 ncbi.nlm.nih.gov/pubmed/19079576(link is external)
     
  27. Dunlap PV, Davis KM, Tomiyama S, Fujino M, Fukui A. Developmental and microbiological analysis of the inception of bioluminescent symbiosis in the marine fish Nuchequula nuchalis (Perciformes: Leiognathidae). 2008. Appl Environ Microbiol, 74(24): 7471-7481. PMID: 18978090 ncbi.nlm.nih.gov/pubmed/18978090(link is external)
     
  28. Ji G, Zheng J, Shen Y, Wu X, Jiang R, Lin Y, Loke JC, Davis KM, Reese GJ, Li QQ. Predictive modeling of plant messenger RNA polyadenylation sites. 2007. BMC Bioinformatics, 8(1): 43. PMID: 17286857 ncbi.nlm.nih.gov/pubmed/17286857(link is external)